Practices to prevent venous thromboembolism: A brief review

BMJ Quality and Safety

Volumn 23, Issue 3, 2014, Pages 187-195

  Lau, Brandyn D ^a   Haut, Elliott R ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION SUPPORT SYSTEM; HOSPITALIZATION; HUMAN; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

DECISION SUPPORT TECHNIQUES; HOSPITALIZATION; HUMANS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84894126317     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs-2012-001782     Document Type: Review

References (51)

1. Guyatt GH, Akl EA, Crowther M, et al. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:7S-47S.
2. Anderson FA Jr, Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007;82:777-82.
3. US Department of Health and Human Services. The surgeon general's call to action to prevent deep vein thrombosis and pulmonary embolism. 2008. http://www.surgeongeneral.gov/ topics/deepvein/ (accessed 30 Aug 2011).
4. Cushman JG, Agarwal N, Fabian TC, et al. Practice management guidelines for the management of mild traumatic brain injury: the EAST practice management guidelines work group. J Trauma 2001;51:1016-26.
5. Haut ER, Lau BD, Streiff MB. New oral anticoagulants for preventing venous thromboembolism. BMJ 2012;344:e3820.
6. Goldhaber SZ, Leizorovicz A, Kakkar AK, et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 2011;365:2167-77.
7. Qaseem A, Chou R, Humphrey L, et al. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;155:625-32.
8. Lederle FA, Zylla D, MacDonald R, et al. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2011;155:602-15.
9. Rogers FB, Cipolle MD, Velmahos G, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma 2002;53:142-64.
10. Mont MA, Jacobs JJ, Boggio LN, et al. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 2011;19:768-76.
11. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793-800.
12. Streiff MB, Lau BD. Thromboprophylaxis in nonsurgical patients. Hematol Am Soc Hematol Educ Program 2012;2012:631-7.
13. Goldhaber SZ, Tapson VF, DVT FREE Steering Committee. A prospective registry of 5451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.
14. Cohen AT, Tapson VF, Bergmann J, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94.
15. Schaden E, Metnitz PG, Pfanner G, et al. Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care. Intensive Care Med 2012;38:984-90.
16. Shojania KG, Duncan BW, McDonald KM, et al. Making health care safer: a critical analysis of patient safety practices. Rockville, MD: Agency for Healthcare Research and Quality. 2001:43.
17. Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. Rockville, MD: Agency for Healthcare Research and Quality. 2008.
18. Shekelle PG,Wachter RM, Pronovost PJ, et al.Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Comparative Effectiveness Review No. 211. (Prepared by the Southern California-RAND Evidence-based Practice Center under Contract No. 290- 2007-10062-I.) AHRQ Publication No. 13-E001-EF. Rockville, MD: Agency for Healthcare Research and Quality, March 2013.
19. Shekelle PG, Pronovost PJ, Wachter RM, et al. The top patient safety strategies that can be encouraged for adoption now. Ann Intern Med 2013;158(5 Part 2):365-8.
20. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241:397-415.
21. Haut ER, Lau BD. Chapter 28: prevention of venous thromboembolism (VTE). Rockville, MD: Agency for Healthcare Research and Quality. Making Health Care Safer II: An Updated Critical Analysis of the Evidence for Patient Safety Practices. Comparative Effectiveness Review No. 211. (Prepared by the Southern California-RAND Evidence-based Practice Center under Contract No. 290-2007-10062-I.) AHRQ Publication No. 13-E001-EF. Rockville, MD: Agency for Healthcare Research and Quality, March 2013.
22. Fan E, Laupacis A, Pronovost PJ, et al. How to use an article about quality improvement. JAMA 2010;304:2279-87.
23. Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA 2011;305:2462-3.
24. Scaglione L, Piobbici M, Pagano E, et al. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 2005;90:678-84.
25. Fanikos J, Stevens LA, Labreche M, et al. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med 2010;123:536-41.
26. Shermock KM, Lau BD, Haut ER, et al. Patterns of nonadministration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. PLoS ONE. (in press)
27. Piazza G, Nguyen TN, Morrison R, et al. Patient education program for venous thromboembolism prevention in hospitalized patients. Am J Med 2012;125:258-64.
28. Liu DS, Lee MM, Spelman T, et al. Medication chart intervention improves inpatient thromboembolism prophylaxis. Chest 2012;141:632-41.
29. O'Connor C, Adhikari NKJ, DeCaire K, et al.Medical admission order sets to improve deep vein thrombosis prophylaxis rates and other outcomes. J HospMed 2009;4:81-9.
30. Fontaine A, Mahe I, Bergmann JF, et al. Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study. J Intern Med 2006;260:369-76.
31. Streiff MB, Carolan H, Hobson DB, et al. Lessons from the John Hopkins multi-disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;344:e3935.
32. Lesselroth BJ, Yang J, McConnachie J, et al. Addressing the sociotechnical drivers of quality improvement: a case study of post-operative DVT prophylaxis computerised decision support. BMJ Qual Saf 2011;20:381-9.
33. Beeler PE, Kucher N, Blaser J. Sustained impact of electronic alerts on rate of prophylaxis against venous thromboembolism. Thromb Haemost 2011;106:734-8.
34. Kucher N, Tapson VF, Goldhaber SZ, et al. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost 2005;93:494-8.
35. Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. JAMA 2009;301:1063-5.
36. Haut ER, Lau BD, Kraenzlin FS, et al. Improved prophylaxis and decreased preventable harm with a mandatory computerized clinical decision support tool for venous thromboembolism (VTE) prophylaxis in trauma patients. Arch Surg 2012;10:901-7.
37. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009;119:2196-201.
38. Mahan CE, Hussein MA, Amin AN, et al. Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis. Clin Appl Thromb Hemost 2012;18:45-58.
39. Clark BM, d'Ancona G, Kinirons M, et al. Effective quality improvement of thromboprophylaxis in acute medicine. BMJ Qual Saf 2011;20:460-4.
40. Gallagher M, Oliver K, Hurwitz M. Improving the use of venous thromboembolism prophylaxis in an Australian teaching hospital. Qual Saf Health Care 2009;18:408-12.
41. Stinnett JM, Pendleton R, Skordos L, et al. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol 2005;78:167-72.
42. Maynard GA, Morris TA, Jenkins IH, et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med 2010;5:10-18.
43. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994;154:669-77.
44. Roumie CL, Elasy TA, Greevy R, et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 2006;145:165-75.
45. Gómez-Outes A, Terleira-Fernández A, Suárez-Gea M, et al. Dabigatran, rivaroxaban or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis and indirect treatment comparisons. BMJ 2012;344:e3675.
46. Haut ER, Noll K, Efron DT, et al. Can increased incidence of deep vein thrombosis (DVT) be used as a marker of quality of care in the absence of standardized screening' The potential effect of surveillance bias on reported DVTrates after trauma. J Trauma 2007;63:1132-5.
47. Haut ER, Chang DC, Pierce CA, et al. Predictors of posttraumatic deep vein thrombosis (DVT): hospital practice versus patient factors-an analysis of the National Trauma Data Bank (NTDB). J Trauma 2009;66:994-9.
48. Pierce CA, Haut ER, Kardooni S, et al. Surveillance bias and deep vein thrombosis in the national trauma data bank: the more we look, the more we find. J Trauma 2008;64:932-6.
49. Zeidan AM, Streiff MB, Lau BD, et al. Impact of a venous thromboembolism (VTE) prophylaxis 'smart order set': improved compliance, fewer events. Am J Hematol 2013.
50. MonnMF, Haut ER, Lau BD, et al. Is venous thromboembolism in colorectal surgery patients preventable or inevitable: one institution's experience. J Am Coll Surg 2013;216:395-401.
51. Aboagye JK, Lau BD, Schneider EB, et al. Linking processes and outcomes: a key strategy to prevent and report harm from venous thromboembolism in surgical patients. JAMA Surg 2013;148:299-300.